A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP

By sjmartinez • November 29, 2022

Yu Y, Bigos KL, Marzinke MA, Landovitz RJ, McCauley M, Ford S, Hendrix CW, Bies RR, Weld ED; HPTN 077 Study Team. A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP. Br J Clin Pharmacol. 2022 Oct;88(10):4623-4632. doi: 10.1111/bcp.15477. Epub 2022 Aug 14. PMID: 35949044.

Tags: antiretrovirals, HIV/AIDS, Infectious Diseases, infectious diseases, pharmacometrics, Publications

In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic Approach

Youssef EG, Elnesr K, Hanora A. In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using[...]

Cabotegravir pharmacokinetics in Asians with and without HIV

Han K, Abulfathi AA, Mehta RS, Nand RA, Marzinke MA, Landovitz RJ, D'Amico RD, Rinehart AR, Spreen WR, Ford SL. Cabotegravir pharmacokinetics in Asians with[...]

Depression improves the predictive accuracy of the VACS Index 2.0 for all-cause mortality among sexual minority men living with HIV in the Multicenter AIDS Cohort Study

Qian Y, Comulada WS, Hidalgo MA, Lee SJ, Friedman MR, Palella FJ, Plankey MW, D'Souza G, Detels R, Mimiaga MJ. Depression improves the predictive accuracy[...]